Clinical characteristics and treatment of pars planitis: an adalimumab experience

Özdemir H. B., Ozdal P. C.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, cilt.260, sa.2, ss.561-569, 2022 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 260 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1007/s00417-021-05398-4
  • Dergi Adı: GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.561-569
  • Anahtar Kelimeler: Pars planitis, Intermediate uveitis, Immunosuppressive treatment, Anti-tumour necrosis factor treatment, Adalimumab, NONINFECTIOUS UVEITIS, THERAPY, RETINOSCHISIS, MULTICENTER
  • Gazi Üniversitesi Adresli: Evet

Özet

Purpose This study aims to investigate the clinical and demographic characteristics, treatment outcomes and complications of patients with pars planitis.